Medicina (Kaunas, Lithuania)
June 3, 2024
Keming Gao
1 citation
Background and Objectives: Options for treatment-resistant bipolar depression (TRBPD) are limited. Electroconvulsive therapy (ECT) has shown efficacy in TRBPD. However, the cognitive deficits and memory concerns associated with ECT are problematic for a significant number of patients. It remains unclear what the next step is for patients with TRBPD who fail ECT. Materials and Methods: In this...
Frontiers in Pharmacology
June 3, 2024
Gio Kim, Catherine K. Wang, Lily R. Aleksandrova et al.
3 citations
One of the most important developments in psychopharmacology in the past decade has been the emergence of novel treatments for mood disorders, such as psilocybin for treatment-resistant depression. Psilocybin is most commonly found in different species of mushroom; however, the literature on mushroom and fungus extracts with potential antidepressant activity extends well beyond just...
Bulletin of Counseling and Psychotherapy
June 1, 2024
Made Arisudana, Ananta Yudiarso
This meta-analysis investigates the effectiveness of Mindfulness-Based Cognitive Therapy (MBCT) in addressing depression across diverse contexts. Drawing from 13 studies, it examines the impact of MBCT on depressive symptoms using various measurement tools such as the Depression Anxiety and Stress Scale (DASS) and Beck-Depression Inventory (BDI). The findings underscore the importance of...
Bipolar Disorders
June 1, 2024
Rakesh Kumar, Nicolas A. Nunez, Neha Joshi et al.
AbstractBackgroundKetamine is increasingly used for treatment‐resistant depression (TRD) while its mechanism of action is still being investigated. In this systematic review, we appraise the current evidence of metabolomic biomarkers for racemic ketamine and esketamine in patients with TRD and healthy controls (HCs).MethodsA comprehensive search of several databases (Ovid MEDLINE®, Embase, and...
BJPsych Open
June 1, 2024
Bikramaditya Jaiswal, Neha Singh, Benson Benjamin
AimsThe primary aim of this rapid review was to evaluate the evidence base for the efficacy of ketamine across all formulations and routes of administrations in the treatment of adult patients with treatment resistant depression (TRD).MethodsThis rapid review retrieved controlled trials on use of ketamine across all of its formulations, including all isomers and across all routes of...
The International Journal of Neuropsychopharmacology
June 1, 2024
Mina M Rizk, James W. Murrough
In this issue of the Journal
Psychiatric Annals
June 1, 2024
Syed Iqbal, Ronak Patel, Zeshan Barlas et al.
Ketamine is an N-methyl-D-aspartate (NMDA) receptor antagonist that has antidepressant and antisuicidal effects, as shown by multiple studies done over the past two decades, that can be used effectively in the management of treatment-resistant depression (TRD). The United States Food and Drug Administration has approved intranasal (S)-ketamine in combination with an oral antidepressant for TRD....
International Journal of Social Psychiatry
June 1, 2024
Anu James Vibin, Niharika Niharika, Varun Valliappan et al.
2 citations
Depression is a leading cause of disability and the conventional management has several limitations. Recent studies demonstrated the benefits of yoga in psychological disorders. To evaluate the efficacy of the Integrated Yoga Module (IYM) to standard care with added yogic education on lifestyle modification (YELM) in patients with clinical depression. A PROBE trial was conducted at a single...
Autism
June 1, 2024
Chad Stecher, Broc A. Pagni, Sara Cloonan et al.
11 citations
Existing research has identified an increased risk of depression among autistic adults, which can negatively impact their adaptive functioning abilities and socioeconomic outcomes. Mobile app-based meditation is a feasible, accessible, and effective self-care solution for depression among neurotypical adults, but there is limited evidence for the long-term benefits of app-based meditation among...
Journal of Integrative and Complementary Medicine
June 1, 2024
Holger C Bringmann, Anne Berghöfer, Michael Jeitler et al.
3 citations
Objective: Understanding the relevance of religion or spirituality (R/S) in the treatment of mental disorders is central to clinical and academic psychiatry. In this secondary analysis, associations of R/S with depression were investigated with respect to a new second-generation mindfulness-based intervention, the Meditation-Based Lifestyle Modification (MBLM) program. Methods: Different...